Both in Biotechnology
Fennec Pharmaceuticals vs Eikon Therapeutics
Over the past year FENC returned +33.7% and EIKN returned −64.6%; their daily moves had a correlation of 0.27.
FENC +33.7% EIKN −64.6%Growth of $1, one year, split-adjusted
| Metric | FENC | EIKN |
|---|---|---|
| Price | $10.24 | $5.31 |
| Market cap | $359.1M | $287.6M |
| Today | −6.48% | −0.75% |
| 1 month | −0.9% | −28.3% |
| 6 months | +56.6% | −45.1% |
| Year to date | +33.0% | — |
| 1 year | +20.9% | — |
| Revenue growth (YoY) | +85.2% | — |
| Gross margin | 96.0% | — |
| Net margin | 11.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | — |
| Net cash | $41.2M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 99.4% |
| Short % of float | 2.2% | 20.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).